Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Daniel Echeverría Esnal"'
Autor:
Alicia Rodríguez-Alarcón, Manuela Sanz de Mena, Soukaina Sara Alanti, Daniel Echeverría-Esnal, Luisa Sorli, Elena Sendra, Adela Benítez-Cano, Estela Membrilla, Francesc Cots, Robert Güerri-Fernández, Ramón Adalia, Juan Pablo Horcajada, Fernando Escolano, Santiago Grau, Silvia Gómez-Zorrilla
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Penicillin allergy labels (PAL) are common in the hospital setting and are associated with worse clinical outcomes. Desensitization can be a useful strategy for allergic patients when alternative options are suboptimal or not available.
Externí odkaz:
https://doaj.org/article/467edd1e1e73488b9468f0873b3085f5
Autor:
Nuria Carballo, Carolina Pérez García, Santiago Grau, Jordi Monfort, Xavier Durán-Jordà, Daniel Echeverría-Esnal, Olivia Ferrández
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Although several randomized clinical trials have confirmed that there is no difference in efficacy between etanercept and its biosimilar versions in the treatment of rheumatoid arthritis (RA), limited real-world evidence is available. We conducted a
Externí odkaz:
https://doaj.org/article/50fe152024be49b7ab243564e0da6217
Autor:
Membrilla Fernández, Estela, Gómez Zorrilla, Silvia, González-Castillo, Ana María, Pelegrina-Manzano, Amalia, Guzmán-Ahumada, Juan, Prim, Núria, Daniel, Echeverría-Esnal, Grau-Cerrato, Santiago, Horcajada, Juan Pablo, Badia, Josep M, Sancho Insenser, Juan Jose
Publikováno v:
Cirugía Española. 100:608-613
El aumento progresivo de las resistencias antibióticas apremia el tener estrategias para disminuir la presión sobre la microbiota. La duración del tratamiento antibiótico empírico es variable, a pesar de las recomendaciones de las guías. Se ha
Autor:
Santiago Grau, Sergi Hernández, Daniel Echeverría-Esnal, Alexander Almendral, Ricard Ferrer, Enric Limón, Juan Pablo Horcajada, on behalf of the Catalan Infection Control Antimicrobial Stewardship Program (VINCat-PROA)
Publikováno v:
Antibiotics, Vol 10, Iss 8, p 943 (2021)
Background: Antimicrobials have been widely used during the COVID-19 pandemic. This study aimed to analyze the impact of the COVID-19 pandemic on the antimicrobial consumption of 66 hospitals in Catalonia. Methods: Adult antibacterial and antimycotic
Externí odkaz:
https://doaj.org/article/fbfbc62637f240aa91fceb761d2b19f0
Autor:
Daniel Echeverría-Esnal, Luisa Sorli, Nuria Prim, Clara Martin-Ontiyuelo, Juan Pablo Horcajada, Santiago Grau
Publikováno v:
Antibiotics, Vol 10, Iss 6, p 716 (2021)
Background: Ampicillin resistant and glycopeptide susceptible Enterococcus faecium bloodstream infection (GSEF-BSI) incidence has risen. However, the treatment of choice remains unknown. Daptomycin use for the treatment of enterococcal infections has
Externí odkaz:
https://doaj.org/article/9684b3da947d46a691a31203699ef365
Autor:
Javier Martínez-Casanova, Silvia Gómez-Zorrilla, Nuria Prim, Agustina Dal Molin, Daniel Echeverría-Esnal, María Pilar Gracia-Arnillas, Elena Sendra, Robert Güerri-Fernández, Xavier Durán-Jordà, Eduardo Padilla, Juan Pablo Horcajada, Santiago Grau, on behalf of the PROA-PSMAR Group
Publikováno v:
Antibiotics, Vol 10, Iss 5, p 582 (2021)
Background: High rates of amoxicillin-clavulanate (AMC) resistance among Enterobacterales isolated from urinary tract infections (UTIs) were observed in our area. The aim of this study was to identify risk factors associated with AMC resistance in pa
Externí odkaz:
https://doaj.org/article/8a60b986b7954d489aa0e9f418639c92
Publikováno v:
Expert Review of Anti-infective Therapy. 20:645-647
Autor:
Jesús Ares, Daniel Echeverría-Esnal, Robert Güerri-Fernández, Nuria Campillo, Guillem Deus, Emili Letang, Ana Siverio, Hernando Knobel, Juan Pablo Horcajada, Silvia Gómez-Zorrilla, Santiago Grau
Publikováno v:
Infection and Drug Resistance
Background: Skeletal involvement of Cryptococcus neoformans is infrequent and usually associated with disseminated cryptococcosis or underlying predisposing conditions. We present an atypical case of osteoarticular cryptococcosis in an immunocompeten
Autor:
Xavier Monzonis, Daniel Echeverría-Esnal, Inés Monge-Escartín, Edurne Arriola, L. Moliner, Álvaro Taus, Xavier Duran-Jordà, Alejandro Ríos-Hoyo, David Conde-Estévez
Publikováno v:
Journal of Chemotherapy. 33:32-39
Our aim was to describe the incidence and characteristics of immune-related adverse events (irAEs) in patients with non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI) and to evaluate their impact on outcome. All cases
Autor:
Santiago Grau, Olivia Ferrández, Juan Pablo Horcajada, Clara Martín-Ontiyuelo, María Eugenia Navarrete-Rouco, Daniel Echeverría-Esnal, Marta De-Antonio Cuscó
Publikováno v:
Expert Review of Anti-infective Therapy
Introduction: SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19). Antiviral and immunomodulatory agents have been proposed as potential treatments. Azithromycin exhibits both properties and therefore may play a role. Areas cove